CHARLES GAINOR: Open Payments
NPI 1881648186 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 43 payments from 12 companies in 2025. Trend: 2023 $417 · 2024 $891 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $187 |
| PFIZER INC. | 7 | $114 |
| Gilead Sciences, Inc. | 4 | $108 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
| Lilly USA, LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| SCILEX PHARMACEUTICALS INC. | 1 | $22 |
| Viatris Specialty LLC | 1 | $22 |
Products named: NURTEC ODT, QULIPTA, Belbuca, VRAYLAR, MOUNJARO, REXULTI, UBRELVY, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
